VJHemOnc is committed to improving our service to you

VJVirtual | Repeat infusions of CD19 CAR-T

VJHemOnc is committed to improving our service to you

Jordan Gauthier

Jordan Gauthier, MD, Fred Hutchinson Cancer Research Center, Seattle, WA, talks on the deepening of responses in patients previously treated with CD19 CAR-T cells by using repeated infusions of the cellular therapy. Dr Gauthier goes on to outline how the use of fully humanized CAR-T cells may reduce immunogenicity. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter